174 related articles for article (PubMed ID: 22772870)
1. Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.
Cho YK; Choi MG; Bak YT; Rhee PL; Kim SG; Jung HY; Seol SY
Dig Dis Sci; 2012 Dec; 57(12):3189-94. PubMed ID: 22772870
[TBL] [Abstract][Full Text] [Related]
2. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
Moraes-Filho JP; Pedroso M; Quigley EM;
Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
[TBL] [Abstract][Full Text] [Related]
4. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
5. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Koop H; Schepp W; Dammann HG; Schneider A; Lühmann R; Classen M
J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of pantoprazole magnesium and pantoprazole sodium in the treatment of gastro-oesophageal reflux disease: a randomized, double-blind, controlled, multicentre trial.
Hein J
Clin Drug Investig; 2011; 31(9):655-64. PubMed ID: 21819161
[TBL] [Abstract][Full Text] [Related]
7. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
Holtmann G; Cain C; Malfertheiner P
Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
[TBL] [Abstract][Full Text] [Related]
8. Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis.
Baker R; Tsou VM; Tung J; Baker SS; Li H; Wang W; Rath N; Maguire MK; Comer GM
Clin Pediatr (Phila); 2010 Sep; 49(9):852-65. PubMed ID: 20522615
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease.
Pai VG; Pai NV; Thacker HP; Shinde JK; Mandora VP; Erram SS
World J Gastroenterol; 2006 Oct; 12(37):6017-20. PubMed ID: 17009401
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
14. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
15. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
Richter JE; Bochenek W
Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
Meneghelli UG; Boaventura S; Moraes-Filho JP; Leitão O; Ferrari AP; Almeida JR; Magalhães AF; Castro LP; Haddad MT; Tolentino M; Jorge JL; Silva E; Maguilnik I; Fischer R
Dis Esophagus; 2002; 15(1):50-6. PubMed ID: 12060043
[TBL] [Abstract][Full Text] [Related]
17. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (GERD): a prospective, multicenter, post-marketing observational study.
Remes-Troche JM; Sobrino-Cossío S; Soto-Pérez JC; Teramoto-Matsubara O; Morales-Arámbula M; Orozco-Gamiz A; Tamayo de la Cuesta JL; Mateos G
Clin Drug Investig; 2014 Feb; 34(2):83-93. PubMed ID: 24347282
[TBL] [Abstract][Full Text] [Related]
19. Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Lühmann R; Sander P; Tholen A
BMC Gastroenterol; 2013 Oct; 13():145. PubMed ID: 24083350
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.
Calleja JL; Suarez M; De Tejada AH; Navarro A;
Dig Dis Sci; 2005 Mar; 50(3):432-9. PubMed ID: 15810621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
